This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Dec;6(12):661-3.

doi: 10.1038/nrendo.2010.191.

Postmenopausal hormone therapy: risks versus benefits reassessed

James A Simon¹

Affiliations

Affiliation

¹ Department of Obstetrics and Gynecology, George Washington University, 1850 M Street Northwest, Suite 450, Washington, DC 20036, USA. jsimon@jamesasimonmd.com

PMID: 21102647
DOI: 10.1038/nrendo.2010.191

Postmenopausal hormone therapy: risks versus benefits reassessed

James A Simon. Nat Rev Endocrinol. 2010 Dec.

. 2010 Dec;6(12):661-3.

doi: 10.1038/nrendo.2010.191.

Author

James A Simon¹

Affiliation

¹ Department of Obstetrics and Gynecology, George Washington University, 1850 M Street Northwest, Suite 450, Washington, DC 20036, USA. jsimon@jamesasimonmd.com

PMID: 21102647
DOI: 10.1038/nrendo.2010.191

No abstract available

PubMed Disclaimer

Similar articles

The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
Chlebowski RT, Anderson GL. Chlebowski RT, et al. J Natl Cancer Inst. 2011 Feb 16;103(4):284-5. doi: 10.1093/jnci/djq561. Epub 2011 Jan 28. J Natl Cancer Inst. 2011. PMID: 21278357 No abstract available.
Weighing the risks and benefits of hormone therapy.
Toth S, Blanchard E, Herman L, Larson L, Léger MM, McNellis R, Quigley T, Van Dyke E. Toth S, et al. JAAPA. 2003 Jun;16(6):45-7. JAAPA. 2003. PMID: 14968505 Review. No abstract available.
Health risks after cessation of postmenopausal hormone therapy.
Pines A, Sturdee D, Birkhäuser M; International Menopause Society. Pines A, et al. Climacteric. 2008 Jun;11(3):179-80. doi: 10.1080/13697130802176228. Climacteric. 2008. PMID: 18568782 No abstract available.
[Evidence based basis of decision making for or against a postmenopausal hormone treatment].
Rásky E. Rásky E. Wien Klin Wochenschr. 2004 Jul 31;116(14):461-4; discussion 504. doi: 10.1007/BF03040940. Wien Klin Wochenschr. 2004. PMID: 15379140 German. No abstract available.
Hormonal replacement therapy in breast cancer.
Pritchard KI. Pritchard KI. Ann Oncol. 2002;13 Suppl 4:73-80. doi: 10.1093/annonc/mdf642. Ann Oncol. 2002. PMID: 12401670 Review. No abstract available.

See all similar articles

Cited by

A meta-analysis of reference values of leptin concentration in healthy postmenopausal women.
Zhou X, Chai Y, Chen K, Yang Y, Liu Z. Zhou X, et al. PLoS One. 2013 Aug 30;8(8):e72734. doi: 10.1371/journal.pone.0072734. eCollection 2013. PLoS One. 2013. PMID: 24023638 Free PMC article.

References

1. Cleve Clin J Med. 2008 May;75 Suppl 4:S3-12 - PubMed
1. J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66 - PubMed
1. Obstet Gynecol. 2001 Jan;97(1):97-100 - PubMed
1. Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):146-7 - PubMed
1. Nat Clin Pract Endocrinol Metab. 2007 Jul;3(7):496-7 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.